发明名称 |
Inducing cellular immune responses to her2/neu using peptide and nucleic acid compositions |
摘要 |
This invention uses our knowledge of the mechanisms by which antigen is recognized by T cells to identify and prepare HER2/new epitopes, and to develop epitope-based vaccines directed towards HERS2/neu-bearing tumors. More specifically, this application communicates our discovery of pharmaceutical compositions and methods of use in the prevention and treatment of cancer. |
申请公布号 |
AU2087401(A) |
申请公布日期 |
2001.06.18 |
申请号 |
AU20010020874 |
申请日期 |
2000.12.11 |
申请人 |
EPIMMUNE, INC. |
发明人 |
JOHN FIKES;ALESSANDRO SETTE;JOHN SIDNEY;SCOTT SOUTHWOOD;ROBERT CHESNUT;ESTEBAN CELIS;ELISSA KEOGH |
分类号 |
C12N15/09;A61K38/03;A61K39/00;A61K39/39;A61P35/00;C07K7/06;C07K7/08;C07K14/47;C07K14/705;C07K14/71;C07K14/725;C12N5/10 |
主分类号 |
C12N15/09 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|